COVID-19

News

Doubts over US government plans for COVID-19 vaccine

There are doubts about the US government's plans to have 300 million COVID-19 vaccine doses ready by the end of the year, after the front-running candidate from Moderna advanced to mid-stag

News

Japan approves Gilead's COVID-19 drug remdesivir

Japan’s regulator has quickly approved Gilead’s remdesivir for patients with severe COVID-19, after the FDA allowed its use as an emergency treatment for the disease earlier this month.

News

Gilead working with generics firms to boost global supply of...

Gilead has outlined plans to work with generics firms to rapidly increase production of its COVID-19 drug remdesivir to meet global demand.

Views & Analysis

4 tips for switching to virtual meetings

Coronavirus has forced pharma companies to take their meetings online – including everything from small team calls to major congresses.

News

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

Pfizer and its development partner BioNTech have begun dosing the first people in the US with a potential COVID-19 vaccine, as part of their ongoing phase 1/2 clinical trial.

News

BerGenBio raises 45 million euros for COVID-19 drug developm...

Norway’s BerGenBio has raised 500 million Norwegian kroner – around $45.4 million euros – in an oversubscribed private placement to develop its pipeline that includes a potential COVID-19 t

Doubts over US government plans for COVID-19 vaccine

Japan approves Gilead's COVID-19 drug remdesivir

Gilead working with generics firms to boost global supply of...

4 tips for switching to virtual meetings

Pfizer/BioNTech dose first US patients with COVID-19 vaccine

BerGenBio raises 45 million euros for COVID-19 drug developm...

RNAi biotech City hauls in $200m in upsized IPO

Discover a new era of healthcare panel engagement: Grounded ...

COVID-19

Editor's Picks